Literature DB >> 8778269

Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.

H R Siebner1, S Berndt, B Conrad.   

Abstract

A 39 year old patient with cerebellar signs, juvenile cataracts, and dull normal intelligence had cerebrotendinous xanthomatosis without tendon xanthomas, diagnosed previously as Marinesco-Sjoegren syndrome. Cerebrotendinous xanthomatosis was proved by a greatly increased excretion of bile alcohols in the patient's urine. Cerebrotendinous xanthomatosis is a sterol storage disorder due to an autosomal recessive inherited defect of sterol 27-hydroxylase characterised by high cholestanol concentration in multiple tissues. If tendon xanthomas are not present, a diagnosis of cerebrotendinous xanthomatosis will often not be made, unless biochemical tests are performed. The clinical features of cerebrotendinous xanthomas strongly resembles Marinesco-Sjoegren syndrome. Marinesco-Sjoegren syndrome is a autosomal recessive disorder characterised by the triad cerebellar ataxia, congenital cataract, and mental retardation. Although a late onset after the first decade of life favours cerebrotendinous xanthomatosis as the underlying disease, a definite distinction between cerebrotendinous xanthomatosis without tendon xanthomas and Marinesco-Sjoegren syndrome based on clinical presentation may be difficult. It is considered that some patients with Marinesco-Sjoegren syndrome reported in the medical literature had cerebrotendinous xanthomatosis without tendon xanthomas. This is of crucial clinical relevance, because, by contrast with Marinesco-Sjoegren syndrome, treatment for cerebrotendinous xanthomatosis is already available.

Entities:  

Mesh:

Year:  1996        PMID: 8778269      PMCID: PMC486377          DOI: 10.1136/jnnp.60.5.582

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Mitochondrial myopathy in Marinesco-Sjögren syndrome.

Authors:  T Torbergsen; J Aasly; O Borud; S Lindal; S I Mellgren
Journal:  J Ment Defic Res       Date:  1991-04

2.  Hereditary cerebellar ataxia associated with congenital cataracts. 4 cases of the Marinesco-Sjögren syndrome with some unusual features.

Authors:  R Nyberg-Hansen; O Gronvik
Journal:  Acta Neurol Scand Suppl       Date:  1972

3.  [Familial syndrome of the Marinesco-Sjogren type with variations].

Authors:  P Monnet; L Paufique; B Salle; D Rosenberg; N Pasquier; S Picaud
Journal:  Arch Fr Pediatr       Date:  1969-01

4.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis.

Authors:  J J Cali; C L Hsieh; U Francke; D W Russell
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.

Authors:  J Peynet; A Laurent; P De Liege; P Lecoz; P Gambert; A Legrand; J Mikol; A Warnet
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

6.  Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease.

Authors:  V Meiner; Z Meiner; A Reshef; I Björkhem; E Leitersdorf
Journal:  Neurology       Date:  1994-02       Impact factor: 9.910

7.  Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neuroradiological study.

Authors:  V M Berginer; J Berginer; A D Korczyn; R Tadmor
Journal:  J Neurol Sci       Date:  1994-03       Impact factor: 3.181

8.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

Authors:  V M Berginer; G Salen; S Shefer
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

9.  Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in The Netherlands.

Authors:  R J Waterreus; B J Koopman; B G Wolthers; H J Oosterhuis
Journal:  Clin Neurol Neurosurg       Date:  1987       Impact factor: 1.876

10.  Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.

Authors:  B J Koopman; B G Wolthers; J C van der Molen; W van der Slik; R J Waterreus; A van Spreeken
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  6 in total

1.  'Hot cross bun' sign in a case of cerebrotendinous xanthomatosis: a rare neuroimaging observation.

Authors:  Rajendra Singh Jain; Raghavendra Bakki Sannegowda; Amit Agrawal; Deepika Hemrajani; Rahul Jain; Tarun Mathur
Journal:  BMJ Case Rep       Date:  2013-02-14

2.  Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.

Authors:  A Mignarri; S Rossi; M Ballerini; G N Gallus; M Del Puppo; P Galluzzi; A Federico; M T Dotti
Journal:  J Neurol       Date:  2010-11-21       Impact factor: 4.849

3.  Cerebrotendinous xanthomatosis: a rare genetic disorder.

Authors:  Rohan Arjun Bhojwani; Rajashree Khot
Journal:  BMJ Case Rep       Date:  2011-09-05

4.  Cerebrotendinous xanthomatosis; a genetic condition: Clinical profile of three patients from a rural Indian family and review of literature.

Authors:  Vikas Saxena; Pavan Pradhan
Journal:  J Clin Orthop Trauma       Date:  2016-03-04

Review 5.  Inborn errors of metabolism and motor disturbances in children.

Authors:  A García-Cazorla; N I Wolf; M Serrano; B Pérez-Dueñas; M Pineda; J Campistol; E Fernández-Alvarez; J Colomer; S DiMauro; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-10       Impact factor: 4.982

6.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.